In contrast, activating mutations of FMS-like tyrosine kinase 3 (FLT3) are almost exclusively found in ETP-ALL [19, 35–38], suggesting a role for aberrant FLT3 signaling in this high-risk subtype of T-ALL. This evidence concerns the gene FLT3 and acute lymphoblastic leukemia.